1. Home
  2. TCRX vs UFG Comparison

TCRX vs UFG Comparison

Compare TCRX & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • UFG
  • Stock Information
  • Founded
  • TCRX 2018
  • UFG 2021
  • Country
  • TCRX United States
  • UFG Singapore
  • Employees
  • TCRX N/A
  • UFG N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • UFG Oil Refining/Marketing
  • Sector
  • TCRX Health Care
  • UFG Energy
  • Exchange
  • TCRX Nasdaq
  • UFG Nasdaq
  • Market Cap
  • TCRX 91.7M
  • UFG 79.1M
  • IPO Year
  • TCRX 2021
  • UFG 2025
  • Fundamental
  • Price
  • TCRX $1.91
  • UFG $5.46
  • Analyst Decision
  • TCRX Strong Buy
  • UFG
  • Analyst Count
  • TCRX 5
  • UFG 0
  • Target Price
  • TCRX $9.40
  • UFG N/A
  • AVG Volume (30 Days)
  • TCRX 208.8K
  • UFG 2.1M
  • Earning Date
  • TCRX 08-12-2025
  • UFG 01-01-0001
  • Dividend Yield
  • TCRX N/A
  • UFG N/A
  • EPS Growth
  • TCRX N/A
  • UFG N/A
  • EPS
  • TCRX N/A
  • UFG 0.01
  • Revenue
  • TCRX $6,961,000.00
  • UFG $155,193,013.00
  • Revenue This Year
  • TCRX $255.18
  • UFG $31.30
  • Revenue Next Year
  • TCRX N/A
  • UFG $24.99
  • P/E Ratio
  • TCRX N/A
  • UFG $1,031.40
  • Revenue Growth
  • TCRX N/A
  • UFG 119.24
  • 52 Week Low
  • TCRX $1.02
  • UFG $1.15
  • 52 Week High
  • TCRX $6.23
  • UFG $7.70
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 59.09
  • UFG 60.70
  • Support Level
  • TCRX $1.73
  • UFG $3.93
  • Resistance Level
  • TCRX $1.95
  • UFG $7.70
  • Average True Range (ATR)
  • TCRX 0.12
  • UFG 0.86
  • MACD
  • TCRX 0.01
  • UFG 0.10
  • Stochastic Oscillator
  • TCRX 84.85
  • UFG 43.15

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

Share on Social Networks: